Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

THYROXINE (T4) - ANVISA Registration 82533950116

Access comprehensive regulatory information for THYROXINE (T4) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82533950116 and manufactured by ZYBIO INC.. The registration is held by MR SAUDE LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ORTHO-CLINICAL DIAGNOSTICS, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
82533950116
Registration Details
ANVISA Registration Number: 82533950116
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

T4 (Imunofluorescรชncia)
Risk Class II

Registration Details

82533950116

25351130737202563

26386899000116

Company Information

ZYBIO INC.
China
PT: CHINA, REPรšBLICA POPULAR

Dates and Status

Sep 08, 2025

VIGENTE

09/18/2025 19:00:01